Lyric Bio
Pre-clinicalLyric Bio, Inc. is building next generation biomanufacturing for human donor sourced therapeutics.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $8M
About
Lyric Bio, Inc. is building next generation biomanufacturing for human donor sourced therapeutics.
RNA TherapeuticsOncology
Funding History
1Total raised:$8M
Seed$8MMar 15, 2022